Table 1.
UC high fatigue (N = 116) | UC no/mild fatigue (N = 172) | p | |
---|---|---|---|
Years of age, mean (min–max) | 39 (19–69) | 44 (18–73) | <.01 |
Female gender, n (%) | 61 (52) | 55 (32) | <.01 |
Mean disease duration (SD), years | 11 (9) | 14 (12) | .02 |
Proctitis/left sided/ extensive, % | 18/27/55 | 18/31/51 | .74 |
Primary sclerosing cholangitis, n (%) | 1 (1) | 7 (4) | .15 |
5-ASA, oral, n (%)a | 92 (79) | 123 (72) | .17 |
5-ASA, topical, n (%)a | 7 (6) | 3 (2) | .10 |
Thiopurines, n (%)a | 23 (20) | 30 (17) | .64 |
Anti-TNF-α, n (%)a | 9 (8) | 7 (4) | .20 |
Corticosteroids, oral, n (%)a | 0 (0) | 1 (0) | 1.00 |
Corticosteroids, topical, n (%)a | 3 (3) | 0 (0) | .06 |
Ongoing treatment prior to study visit.